Sign in →

Test Code PLFA Cryptococcus Antigen Screen, Lateral Flow Assay, Pleural Fluid


Additional Testing Requirements


Pleural fluid testing for cryptococcal antigen should also be submitted for routine fungal culture. Order FGEN / Fungal Culture, Routine.



Specimen Required


Container/Tube: Sterile vial

Specimen Volume: 0.5 mL


Useful For

Diagnosis of infection with Cryptococcus species

Disease States

  • Cryptococcosis

Method Name

Lateral Flow Assay (LFA)

Reporting Name

Cryptococcus Ag Screen, LFA, PF

Specimen Type

Pleural Fluid

Specimen Minimum Volume

0.25

Specimen Stability Information

Specimen Type Temperature Time Special Container
Pleural Fluid Refrigerated (preferred) 21 days
  Frozen  30 days

Reject Due To

All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Clinical Information

Cryptococcosis is an invasive fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. C neoformans has been isolated from several sites in nature, particularly weathered pigeon droppings. C gattii was previously associated with tropical and subtropical regions only; however, more recently this organism has also been found to be endemic in British Columbia, along the Pacific Northwest, and in the Southeastern United States.

 

Infection is usually acquired via the pulmonary route. Patients are often unaware of any exposure history. Approximately half of the patients with symptomatic disease have a predisposing immunosuppressive condition such as AIDS, steroid therapy, lymphoma, or sarcoidosis. Symptoms may include fever, headache, dizziness, ataxia, somnolence, and cough. While the majority of C neoformans infections occur in immunocompromised patient populations, C gattii has a higher predilection for infection of healthy individuals.

 

In addition to the lungs, cryptococcal infections frequently involve the central nervous system (CNS), particularly in patients infected with HIV. Mortality among patients with CNS cryptococcosis may approach 25% despite antibiotic therapy. Untreated CNS cryptococcosis is invariably fatal. Disseminated disease may affect any organ system and usually occurs in immunosuppressed individuals.

Reference Values

Negative

Day(s) Performed

Monday through Sunday

Report Available

Same day/1 to 2 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

87899-Cryptococcus Ag Screen, LFA, PF

87899-Cryptococcus Ag Titer, LFA, PF (if appropriate)

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
PLFAT Cryptococcus Ag Titer, LFA, PF No No

Forms

If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.